Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Halozyme Therapeutics, Inc. (NASDAQ: HALO)
HALO Stock Predictions and Ratings
WSX Rating:
STRONG BUY
WSX Forecast (1yr):
24.70%
Analyst Rating:
BUY
Analyst Forecast (1yr):
11.60%
HALO Stock Analysis
HALO
PE Ratio:
24.4
HALO
PEG Ratio:
1.2
HALO
Forward EPS Growth (12 month):
21.10%
HALO
PS Ratio:
5.5
HALO
PSG Ratio:
0.4
HALO
Forward Revenue Growth (12 month):
12.60%
HALO Articles
No data was found